BioLife Solutions, Inc. (BLFS) Stock Analysis
DELISTED
What happened to BioLife Solutions, Inc. (BLFS) stock?
BioLife Solutions, Inc. (BLFS) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
P/E 37.34 means the share price is 37.34 times one year of earnings per share. Market cap $1.89B is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
BioLife Solutions, Inc. (BLFS). BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry. Their products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies.
Last analyzed: May 10, 2026BioLife Solutions, Inc. (BLFS) Healthcare & Pipeline Overview
More about this archive record
Can I still buy BLFS shares?
No. BLFS stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for BLFS elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before BLFS stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to BioLife Solutions, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.